Answers are grounded in this paper and cite their sources.
Contemporary hormonal contraception formulations contain lower doses of estrogen, have new synthetic progestin components, and provide novel methods of delivery that have not been studied extensively in relation to breast cancer risk. Given that hormonal contraception is the leading method of birth control in the United States, it is important to reevaluate risk using current formulations. Recent studies including contemporary hormonal contraception formulations will be described.
No takes yet. Share an insight, caveat, or question.
Nicole D. White (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: